- Home
- OABI
OABI
OmniAb Inc.
as 11-07-2024 3:35pm EST
OmniAb Inc offers therapeutic antibody discovery technologies. The company focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.
Upcoming Earnings Alert:
Get ready for potential market movements as OmniAb Inc. OABI prepares to release earnings report on 12 Nov 2024.
| Founded: | 2012 | Country: | United States |
| Employees: | N/A | City: | EMERYVILLE |
| Market Cap: | 459.1M | IPO Year: | N/A |
| Target Price: | $9.00 | AVG Volume (30 days): | 349.2K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.62 | EPS Growth: | N/A |
| 52 Week Low/High: | $3.56 - $6.72 | Next Earning Date: | 11-12-2024 |
| Revenue: | $21,714,000 | Revenue Growth: | -67.16% |
| Revenue Growth (this year): | -6.99% | Revenue Growth (next year): | 71.78% |
Latest OmniAb Inc. News
OABI Breaking Stock News: Dive into OABI Ticker-Specific Updates for Smart Investing
Business Wire
9 days ago
OmniAb to Participate in Two Investor Conferences in November
Simply Wall St.
16 days ago
3 Promising US Penny Stocks With Market Caps Under $500M
Business Wire
17 days ago
OmniAb to Report Third Quarter 2024 Financial Results on November 12
Simply Wall St.
21 days ago
Is OmniAb (NASDAQ:OABI) In A Good Position To Invest In Growth?
GuruFocus.com
a month ago
OmniAb Inc (OABI) Q2 2024 Earnings Call Highlights: Revenue Growth and Strategic Partnerships ...
MT Newswires
2 months ago
RBC Raises Price Target on OmniAb to $8 From $7, Keeps Outperform Rating
Business Wire
2 months ago
OmniAb to Participate in Two Investor Conferences in September
Simply Wall St.
3 months ago
OmniAb Second Quarter 2024 Earnings: Beats Expectations
Compare OABI vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "OABI OmniAb Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.